References
- Elice F, Rodeghiero F. Hematologic malignancies and thrombosis. Thrombosis Res 2012;129:360–366.
- Khorana A, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006;24: 484–490.
- Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166:458–464.
- Sørensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Eng J Med 2000;343:1846–1850.
- De Stefano V, Za T, Rossi E. Venous thromboembolism in multiple myeloma. Semin Thromb Hemost 2014;40:338–347.
- Blom JW, Vanderschoot JPM, Oostindiër MJ, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006;4:529–535.
- Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 2006;87: 1076–1077.
- Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer. Thrombosis Res 2003;110:167–172.
- Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007;110:2339–2346.
- Ku GH, White RH, Chew HK, et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009;113:3911–3917.
- Melillo L, Grandone E, Colaizzo D, et al. Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis. Acta Haemato 2007;117:215–220.
- De Stefano V, Sorà F, Rossi E, et al. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005;3:1985–1992.
- Mohren M, Markmann I, Jentsch-Ullrich K, et al. Increased risk of venous thromboembolism in patients with acute leukaemia. Br J Cancer 2006;94:200–202.
- Ziegler S, Sperr WR, Knöbl P, et al. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. Thromb Res 2005;115:59–64. See comment in PubMed Commons below
- Guzmán-Uribe P, Rosas-López A, Zepeda-León J, et al. Incidence of thrombosis in adults with acute leukemia: a single center experience in Mexico. Rev Invest Clin 2013;65:130–140.
- Oliver N, Short B, Thein M, et al.Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation. Leuk Lymphoma 2015;14:1–5.
- Imberti D, Vallisa D, Anselmi E, et al. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia. Tumori 2004;90:390–393.
- Herishanu Y, Misgav M, Kirgner I, et al. Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens. Leuk Lymphoma 2004;45:1407–1411.
- Guyatt GH, Akl EA, Crowther M, et al. Antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:7S–47S.
- Hirsh J, Guyatt G, Albers GW, et al. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic and thrombolytic therapy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;141(Suppl 2):7S–47S.
- Caruso V, Iacoviello L, Di Castelnuovo A, et al.Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006;108:2216–2222.
- Frere C, Debourdeau P, Hij A, et al. Therapy for cancer-related thromboembolism. Semin Oncol 2014;41:319–338.
- van Doormaal FF, Di Nisio M, Otten HM, et al.Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer. J Clin Oncol 2011;29:2071–2076.
- Saccullo G, Marietta M, Carpenedo M, et al. Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM). Blood 2013;122:581.
- Siragusa S, Armani U, Carpenedo M, et al; for the Italian Society for Haemostasis and Thrombosis. Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) (1). Thromb Res 2012; 129:e171–176.